期刊文献+

尼可地尔与单硝酸异山梨酯片治疗不稳定型心绞痛的疗效比较 被引量:6

暂未订购
导出
摘要 目的:探讨尼可地尔与单硝酸异山梨酯治疗不稳定性心绞痛的疗效。方法:选取我院2010年1月至2011年3月收治的不稳定型心绞痛患者60例,将其分为2组,尼可地尔组32例,单硝酸异山梨酯片组28例,所有患者均常规口服阿司匹林片、B-受体阻滞剂、他汀类降脂药物,尼可地尔组口服尼可地尔片5mgtid,单硝酸异山梨酯片组口服单硝酸异山梨酯片50mgqd,观察周期为1个月。结果:尼可地尔组的总有效率为78.1%,单硝酸异山梨酯片组的总有效率为46.4%,二者的总有效率比较差异具有统计学意义,P<0.05;尼可地尔组的头痛发生率为3.1%,单硝酸异山梨酯片组的头痛发生率为23.1%,二者比较差异性具有统计学意义,P<0.05。结论:尼可地尔在缓解心绞痛症状,减少心绞痛发生率等方面的作用明显优于单硝酸异山梨酯片,尼可地尔头痛的发生率也明显低于单硝酸异山梨酯片。
作者 黄世明
出处 《求医问药(下半月刊)》 2012年第5期156-156,共1页 Seek Medical and Ask The Medicine
  • 相关文献

参考文献4

二级参考文献6

  • 1Iwai T,Tanonaka K,Motegi K,et al.Nicorandil preserves mitochondrial function during ischemia in perfused rat heart[J].Eur J Pharmacol,2002,446(1-3):119-127.
  • 2Carreira RS,Monteiro P,Kowaltowski AJ,et al.Nicorandil protects cardiac mitochondria against permeability transition induced by ischemia-reperfusion[J].J Bioenerg Biomembr,2008,40(2):95-102.
  • 3Monassier JP.Reperfusion injury in acute myocardial infarction:from bench to cath lab.Part Ⅱ:Clinical issues and therapeutic options[J].Arch Cardiovasc Dis,2008,101(9):565-675.
  • 4Liu J,Long C,Ji B,et al.Myocardial protective effects of nicorandil,an opener of potassium channels on senile rat heart[J].Perfusion,2006,21(3):179-183.
  • 5Hai S,Takemura S,Minamiyama Y,et al.Mitochondrial K(ATP) channel opener prevents ischemia-reperfusion injury in rat liver[J].Transplant Proc,2005,37(1):428-431.
  • 6Olaf O,Michael V,Cohen DM,et al.Mitochondrial KATP channels:role in cardioprotection.Cardiovasc Res,2002,55:429.

共引文献119

同被引文献53

  • 1柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2233
  • 2陆再英,钟南山.内科学[M].第7版.北京;人民卫生出版社,2008:728-860.
  • 3Mizukoshi M, Imanishi T, Tanaka A, et al . Clinical classifica- tion and plaque morphology determined by optical coherence tomography in unstable angina pectoris[-J]. Am J Cardiol, 2010,106(3) : 323-328.
  • 4Zhao Z,Geng J,Ge ZM, et al . Efficacy and safety of atorvasta- tin duringearly hospitalization in elderly patients with unstable angina [J]. Clinical and ExperimentalPharmacology and Physiology, 2009,36(5-6) .. 554-558.
  • 5Kirichenko AA,Mantserova OA,Lebedeva AI, a al . Unstable angina:efficacy and tolerability of therapy with aspirin and as- pirin combined with tielopidine [ J]. Kardiologiia, 2007, 47 (5) :24-27.
  • 6IONA Study Group. Determinants of coronary events in pa- tients with stable angina: results from the impact oS nicorandit in angina study[J]. Am heart J, 2005,150(4):689-692.
  • 7Chu AY, Guilianini F, Barratt BJ, et al.Pharmacogenetic determinants of statin-induced reductions in C-reactive protein[J].Circ Cardiovasc Genet, 2012,5 ( 1 ) : 58-65.
  • 8何勇.低分子肝素钙联合阿托伐他汀钙治疗不稳定性心绞痛68例疗效分析[J].医药前沿,2014,(24):116-117.
  • 9Sun M,Gao X,Zhang D,et al. Identification of biomarkers for unstabale angina by plasma metabolomic profiling[J]. Mol Biosyst,2013,9(12):3059-67.
  • 10Paoli G,Mantovani P,Ardissino D. Pathogenesis of acute coronary syndromes: the activated plaque[J]. Ital Heart J,2005,Suppl 3:5S-11S.

引证文献6

二级引证文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部